Other headlines:Varian unveils interventional angio detectorVI goes down underFDA moves to assess iCAD virtual colonography
Varian Medical introduced its first digital detector designed specifically for interventional angiography. The new PaxScan 3030+ uses an efficient cesium iodide scintillator, optimized for scanning at 40 to 150 kV, to help minimize patient radiation dose over the 30 x 30-cm span of the detector. Although particularly suited for interventional angio, the panel, which delivers up to 30 frames per second and can support 3D conebeam CT capabilities, is also compatible with cardiovascular imaging systems and surgical C-arms.
An Australian vendor of electronic medical records is pairing up with Vital Images to provide advanced visualization. Under the partnership, the Aussie company, DDI Health, will offer Vital Images' technology as its primary advanced imaging delivery system to PACS customers and their referring physicians.
Computer-aided detection specialist iCAD has asked the FDA to clear its VeraLook CAD system for CT colonography. The software, which is currently available commercially in Europe, reconstructs CT data into a 3D model of the colon. An image analysis tool detects and marks structures that may be precancerous polyps.
Women's health specialist Hologic could run into legal problems if the company goes ahead with plans to sell its Adiana Permanent Contraception system in the U.S. The developer of a nonincisional permanent birth control product, Conceptus, has asked the U.S. District Court, Northern District of California to declare that Hologic's planned importation, use, sale, or offer to sell Adiana will infringe several of its U.S. patents. Hologic is best known for digital mammography, but since its acquisition in 2007 of Cytyc, it has become a major player in other areas of women's health, including contraceptive devices.
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.